150 related articles for article (PubMed ID: 1977807)
21. Activation of the alternative pathway of complement in psoriatic lesional skin.
Takematsu H; Tagami H
Dermatologica; 1990; 181(4):289-92. PubMed ID: 2073958
[TBL] [Abstract][Full Text] [Related]
22. The complement system in HIV disease.
Füst G; Ujhelyi E; Hidvégi T; Pálóczi K; Mihalik R; Hollán S; Nagy K; Kirschfink M
Immunol Invest; 1991 Apr; 20(2):231-41. PubMed ID: 1864641
[TBL] [Abstract][Full Text] [Related]
23. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis?
Lood C; Eriksson S; Gullstrand B; Jönsen A; Sturfelt G; Truedsson L; Bengtsson AA
Lupus; 2012 Nov; 21(13):1423-32. PubMed ID: 22878256
[TBL] [Abstract][Full Text] [Related]
24. Alterations in C3, C4, factor B, and related metabolites in septic shock.
Lin RY; Astiz ME; Saxon JC; Saha DC; Rackow EC
Clin Immunol Immunopathol; 1993 Nov; 69(2):136-42. PubMed ID: 8403550
[TBL] [Abstract][Full Text] [Related]
25. Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy.
Buyon JP; Tamerius J; Ordorica S; Young B; Abramson SB
Arthritis Rheum; 1992 Jan; 35(1):55-61. PubMed ID: 1731815
[TBL] [Abstract][Full Text] [Related]
26. Increased concentrations of soluble tumor necrosis factor receptor 75 but not of soluble intercellular adhesion molecule-1 are associated with the decline of CD4+ lymphocytes in HIV infection.
Zangerle R; Fuchs D; Sarcletti M; Gallati H; Reibnegger G; Wachter H; Dierich MP; Möst J
Clin Immunol Immunopathol; 1994 Sep; 72(3):328-34. PubMed ID: 7914841
[TBL] [Abstract][Full Text] [Related]
27. Circulating levels of mannose binding protein in human immunodeficiency virus infection.
Senaldi G; Davies ET; Mahalingam M; Lu J; Pozniak A; Peakman M; Reid KB; Vergani D
J Infect; 1995 Sep; 31(2):145-8. PubMed ID: 8666845
[TBL] [Abstract][Full Text] [Related]
28. Complement activation during CAPD.
Young GA; Kendall S; Brownjohn AM
Nephrol Dial Transplant; 1993; 8(12):1372-5. PubMed ID: 8159307
[TBL] [Abstract][Full Text] [Related]
29. Different patterns of C3 and C4 activation in the varied types of juvenile arthritis.
Miller JJ; Olds LC; Silverman ED; Milgrom H; Curd JG
Pediatr Res; 1986 Dec; 20(12):1332-7. PubMed ID: 3099253
[TBL] [Abstract][Full Text] [Related]
30. Classical pathway complement activation in Kawasaki syndrome.
Kohsaka T; Abe J; Asahina T; Kobayashi N
J Allergy Clin Immunol; 1994 Feb; 93(2):520-5. PubMed ID: 8120278
[TBL] [Abstract][Full Text] [Related]
31. Decreased levels of complement receptor 1 (CD35) on B lymphocytes in persons with HIV infection.
Munson LG; Scott ME; Landay AL; Spear GT
Clin Immunol Immunopathol; 1995 Apr; 75(1):20-5. PubMed ID: 7533682
[TBL] [Abstract][Full Text] [Related]
32. Complement activation in severe Plasmodium falciparum malaria.
Wenisch C; Spitzauer S; Florris-Linau K; Rumpold H; Vannaphan S; Parschalk B; Graninger W; Looareesuwan S
Clin Immunol Immunopathol; 1997 Nov; 85(2):166-71. PubMed ID: 9344699
[TBL] [Abstract][Full Text] [Related]
33. Rocket immunoelectrophoresis of C4 and C4d. A simple sensitive method for detecting complement activation in plasma.
Nitsche JF; Tucker ES; Sugimoto S; Vaughan JH; Curd JG
Am J Clin Pathol; 1981 Nov; 76(5):679-84. PubMed ID: 6794354
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneity of C4d and C3d and their complex formation with serum albumin.
Petersen NE; Teisner B; Folkersen J; Svehag SE
Acta Pathol Microbiol Immunol Scand C; 1987 Aug; 95(4):129-35. PubMed ID: 3499750
[TBL] [Abstract][Full Text] [Related]
35. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
[TBL] [Abstract][Full Text] [Related]
36. Pattern of C3, iC3b, and C3d in patients hospitalized for acute asthma.
Lin RY; Caveliere LF; Lorenzana FG; Go EF; Altman KA
Ann Allergy; 1992 Apr; 68(4):324-30. PubMed ID: 1558328
[TBL] [Abstract][Full Text] [Related]
37. A novel ELISA for the assessment of classical pathway of complement activation in vivo by measurement of C4-C3 complexes.
Zwirner J; Dobos G; Götze O
J Immunol Methods; 1995 Oct; 186(1):55-63. PubMed ID: 7561148
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
[TBL] [Abstract][Full Text] [Related]
39. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
Wouters D; Brouwer MC; Daha MR; Hack CE
Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
[TBL] [Abstract][Full Text] [Related]
40. Complement activation and immune complexes in juvenile rheumatoid arthritis.
Jarvis JN; Pousak T; Krenz M; Iobidze M; Taylor H
J Rheumatol; 1993 Jan; 20(1):114-7. PubMed ID: 8441140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
